World's Best Scientists 2026 revealed!
Francisco Ruiz-Cabello

Francisco Ruiz-Cabello

D-Index & Metrics

Immunology

D-Index
68
Citations
12864
World Ranking
2629
National Ranking
28

Overview

Francisco Ruiz-Cabello is affiliated with the University of Granada in Spain. Their research spans multiple fields, primarily focusing on Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their work extensively covers subfields including Immunology, Oncology, Molecular Biology, Genetics, and Infectious Diseases.

Their main research topics reflect a broad engagement with immune system functionality and disease mechanisms. These include:

  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Liver Disease Diagnosis and Treatment
  • Immunotherapy and Immune Responses
  • Drug-Induced Hepatotoxicity and Protection
  • SARS-CoV-2 and COVID-19 Research
  • Genetic Associations and Epidemiology

Francisco Ruiz-Cabello has contributed to several recent publications, highlighting their involvement in immunology, cancer research, and infectious diseases. Selected recent papers include:

  • "HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy" (2021), published in Cellular and Molecular Immunology
  • "Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset" (2020), published in Frontiers in Immunology
  • "Consensus on Recommendations for Safe Sexual Activity during the COVID-19 Coronavirus Pandemic" (2020), published in Journal of Clinical Medicine
  • "Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients" (2021), published in Journal of Microbiology Immunology and Infection
  • "HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine" (2022), published in Vaccines

The scientist frequently collaborates with peers in their field. Notable co-authors include:

  • Juan Francisco Gutiérrez-Bautista
  • Federico Garrido
  • Natalia Aptsiauri
  • Francisco Perea
  • Per Anderson

Francisco Ruiz-Cabello's research appears in a range of publication venues, with multiple contributions to international journals. These venues include:

  • International Journal of Molecular Sciences
  • Cancers
  • eLife
  • Clinical Kidney Journal
  • Cellular and Molecular Immunology

Best Publications

  • IMPLICATIONS FOR IMMUNOSURVEILLANCE OF ALTERED HLA CLASS I PHENOTYPES IN HUMAN TUMOURS

    Federico Garrido;Francisco Ruiz-Cabello;Teresa Cabrera;Juan J. Pérez-Villar

  • Natural history of HLA expression during tumour development

    Federico Garrido;Teresa Cabrera;Angel Concha;Susan Glew

  • Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury is Influenced by Multiple HLA Class I and II Alleles

    M. Isabel Lucena;Mariam Molokhia;Yufeng Shen;Thomas J. Urban

  • The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

    Ignacio Algarra;Angel García-Lora;Teresa Cabrera;Francisco Ruiz-Cabello

  • Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment.

    Alfonso Serrano;Silvia Tanzarella;Ilaria Lionello;Rosa Mendez

  • Analysis of HLA-E expression in human tumors

    Rosario Marín;Francisco Ruiz-Cabello;Susana Pedrinaci;Rosa Méndez

  • Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.

    C M Cabrera;P Jiménez;T Cabrera;C Esparza

  • High frequency of altered HLA class I phenotypes in invasive breast carcinomas.

    T. Cabrera;A. Collado;M.A. Fernandez;A. Ferron

  • Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.

    R Benitez;Danièle Godelaine;M A Lopez-Nevot;F Brasseur

  • HLA class I antigens in human tumors.

    Federico Garrido;Teresa Cabrera;Miguel Angel Lopez-Nevot;Francisco Ruiz-Cabello

  • Role of Altered Expression of HLA Class I Molecules in Cancer Progression

    Natalia Aptsiauri;Teresa Cabrera;Rosa Mendez;Angel Garcia-Lor

  • Rejection versus escape: the tumor MHC dilemma

    Federico Garrido;Francisco Ruiz-Cabello;Natalia Aptsiauri

  • MHC Class I Antigens and Immune Surveillance in Transformed Cells

    Natalia Aptsiauri;Teresa Cabrera;Angel Garcia-Lora;Miguel Angel Lopez-Nevot

  • Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.

    Jose María Romero;Pilar Jiménez;Teresa Cabrera;José Manuel Cózar

  • Multiple mechanisms underlie HLA dysregulation in cervical cancer.

    C S Brady;J S Bartholomew;Deborah J Burt;Margaret F Duggan-Keen

  • Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.

    Ana B. del Campo;Jon Amund Kyte;Javier Carretero;Svitlana Zinchencko

  • HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas

    López-Nevot Ma;Esteban F;Ferrón A;Gutiérrez J

  • Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy

    Rafael Carretero;José M. Romero;Francisco Ruiz-Cabello;Isabel Maleno

  • Analysis of HLA expression in human tumor tissues

    Teresa Cabrera;Miguel Angel López-Nevot;Jose Juan Gaforio;Francisco Ruiz-Cabello

  • Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

    Pilar Jiménez;Julia Cantón;Antonia Collado;Teresa Cabrera

Frequent Co-Authors

Federico Garrido
Federico Garrido University of Granada
Manuel Romero-Gómez
Manuel Romero-Gómez University of Seville
Alberto Orfao
Alberto Orfao University of Salamanca
Julia Almeida
Julia Almeida University of Salamanca
Javier Martín
Javier Martín Spanish National Research Council
Marcos González
Marcos González University of Salamanca
Anton W. Langerak
Anton W. Langerak Erasmus University Rotterdam
Miguel A. López-Nevot
Miguel A. López-Nevot University of Granada
Peter L. Stern
Peter L. Stern University of Manchester
Miguel Delgado
Miguel Delgado University of Granada

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to a variety of healthcare careers, many of which can be pursued through flexible online degree options. For those interested in nursing, 12-month accelerated nursing programs offer a fast track to becoming a registered nurse while balancing other life commitments.

If you’re looking for an entry point into nursing with less time and cost, consider accredited LPN programs easy to get into. These programs provide practical training and essential skills needed to support patient care in various medical settings.

For advanced practice roles, exploring the easiest online nurse practitioner programs can help you gain specialized knowledge efficiently, preparing you for critical functions in healthcare teams.

Among these advanced options, the mental health field offers focused opportunities with top online PMHNP programs. These provide excellent clinical placement rates to develop expertise in psychiatric-mental health nursing, a growing area in immunology-related care.

Best Scientists Citing Francisco Ruiz-Cabello

Trending Scientists